Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11285138 Method of treating C3 glomerulopathy

Patent 11285138 was granted and assigned to ChemoCentryx on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Methods of treating a human suffering from or susceptible to C3 glomerulopathy comprising administering to the human an effective amount of a C5aR antagonist are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11285138 Method of treating C3 glomerulopathy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo